NCT00039416 2014-02-25Imatinib Mesylate in Treating Patients With MyelofibrosisNational Cancer Institute (NCI)Phase 2 Completed18 enrolled
NCT00025415 2013-02-07Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Completed60 enrolled
NCT00245128 2012-01-13Imatinib Mesylate in Treating Patients With MyelofibrosisOHSU Knight Cancer InstitutePhase 2 Terminated10 enrolled 6 charts